Validation and Compliance

Jun 01, 2012
BioPharm International
In a special anniversary interview, Washington Editor Jill Wechsler speaks with with FDA Deputy Commissioner Deborah Autor about where the agency is headed.
May 01, 2012
BioPharm International
Manufacturers seek clear path to develop safe-use approaches for more risky OTC therapies.
Apr 01, 2012
BioPharm International
Soaring opioid use creates challenges for new drug development and supply-chain control.
Mar 01, 2012
BioPharm International
Social media use raises questions about applying old standards to new information technology.
Feb 01, 2012
BioPharm International
More collaboration and expanded oversight aim to compel manufacturers to follow GMPs.
Jan 01, 2012
BioPharm International
Pressure to approve new user fees opens the door to action on drug shortages, prices, and regulation.
Jan 01, 2012
BioPharm International
Contract organizations must have highly organized teams and plans to accommodate today's audits.
Dec 01, 2011
BioPharm International
Added responsibilities and outside concerns prompt overhaul of agency's structure.
Nov 01, 2011
BioPharm International
By BioPharm International Editors
In a culture of quality, it is important that employees adopt this mindset, not because they have to, but because they understand the importance.
Nov 01, 2011
BioPharm International
Clamor mounts over compromised care and rising costs due to lack of crucial therapies.
native1_300x100
lorem ipsum